Peter J. Bridge

1.9k total citations
60 papers, 1.2k citations indexed

About

Peter J. Bridge is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Peter J. Bridge has authored 60 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 18 papers in Molecular Biology and 7 papers in Hematology. Recurrent topics in Peter J. Bridge's work include BRCA gene mutations in cancer (7 papers), Crystal Structures and Properties (7 papers) and Geochemistry and Geologic Mapping (6 papers). Peter J. Bridge is often cited by papers focused on BRCA gene mutations in cancer (7 papers), Crystal Structures and Properties (7 papers) and Geochemistry and Geologic Mapping (6 papers). Peter J. Bridge collaborates with scholars based in Canada, Australia and United States. Peter J. Bridge's co-authors include David Lillicrap, Steve S. Sommer, Dwight D. Koeberl, Rhett P. Ketterling, C. D. K. Bottema, Howard G. Parsons, M. Eric Hyndman, Jillian S. Parboosingh, James J. Clarkson and Todd J. Anderson and has published in prestigious journals such as Cell, Nucleic Acids Research and American Journal of Psychiatry.

In The Last Decade

Peter J. Bridge

57 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter J. Bridge Canada 20 447 328 128 116 96 60 1.2k
Yuichi Mori Japan 27 307 0.7× 176 0.5× 118 0.9× 71 0.6× 80 0.8× 118 2.1k
Kei Matsumoto Japan 24 646 1.4× 149 0.5× 146 1.1× 94 0.8× 89 0.9× 170 1.9k
Jean‐Paul Moisan France 18 765 1.7× 509 1.6× 178 1.4× 252 2.2× 80 0.8× 38 1.8k
Brian K. Roberts United States 20 323 0.7× 145 0.4× 105 0.8× 137 1.2× 70 0.7× 58 1.7k
Yoshiaki Yamada Japan 31 418 0.9× 260 0.8× 166 1.3× 85 0.7× 37 0.4× 199 3.1k
Emma Moore United States 23 834 1.9× 213 0.6× 237 1.9× 61 0.5× 33 0.3× 37 2.2k
Gerard N. Burrow United States 25 539 1.2× 288 0.9× 159 1.2× 32 0.3× 35 0.4× 78 2.7k
Helen Turner United Kingdom 30 697 1.6× 198 0.6× 311 2.4× 26 0.2× 66 0.7× 84 3.1k
Kristy Lee United States 21 586 1.3× 899 2.7× 158 1.2× 124 1.1× 107 1.1× 55 1.9k
F. A. Beemer Netherlands 28 1.0k 2.3× 637 1.9× 149 1.2× 45 0.4× 26 0.3× 73 2.0k

Countries citing papers authored by Peter J. Bridge

Since Specialization
Citations

This map shows the geographic impact of Peter J. Bridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Bridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Bridge more than expected).

Fields of papers citing papers by Peter J. Bridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Bridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Bridge. The network helps show where Peter J. Bridge may publish in the future.

Co-authorship network of co-authors of Peter J. Bridge

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Bridge. A scholar is included among the top collaborators of Peter J. Bridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Bridge. Peter J. Bridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdel‐Salam, Ghada M. H., Laura Flores‐Sarnat, Jillian S. Parboosingh, et al.. (2010). Muenke syndrome with pigmentary disorder and probable hemimegalencephaly: An expansion of the phenotype. American Journal of Medical Genetics Part A. 155(1). 207–214. 15 indexed citations
2.
Innes, A. Micheil, et al.. (2008). An undiagnosed cytogenetic abnormality results in the misidentification of a Duchenne muscular dystrophy carrier. American Journal of Medical Genetics Part A. 146A(8). 1067–1071.
3.
Samson, C., Paul Bessette, Jocelyne Chiquette, et al.. (2006). No Evidence of BRCA1/2 Genomic Rearrangements in High-Risk French-Canadian Breast/Ovarian Cancer Families. PubMed. 10(2). 104–115. 41 indexed citations
4.
Avard, Denise, Peter J. Bridge, Lucie M. Bucci, et al.. (2006). Partnering in Oncogenetic Research – The INHERIT BRCAs Experience: Opportunities and Challenges. Familial Cancer. 5(1). 3–13. 9 indexed citations
5.
6.
7.
McLeod, D. Ross, Floyd F. Snyder, Peter J. Bridge, & Alfredo Pinto. (2002). Acute hemorrhagic leukoencephalitis in male sibs. American Journal of Medical Genetics. 107(4). 325–329.
8.
Fowler, Joanna S., Nora D. Volkow, Jean Logan, et al.. (2001). Evidence that l-deprenyl treatment for one week does not inhibit mao a or the dopamine transporter in the human brain. Life Sciences. 68(24). 2759–2768. 19 indexed citations
9.
Hyndman, M. Eric, Peter J. Bridge, J. Wayne Warnica, Gordon H. Fick, & Howard G. Parsons. (2000). Effect of heterozygosity for the methionine synthase 2756 A→G mutation on the risk for recurrent cardiovascular events. The American Journal of Cardiology. 86(10). 1144–1146. 35 indexed citations
10.
Graham, Gail E., Lisa M. Graham, Peter J. Bridge, et al.. (2000). Further Evidence for Genetic Heterogeneity in Familial Hemophagocytic Lymphohistiocytosis (FHLH). Pediatric Research. 48(2). 227–232. 19 indexed citations
11.
Hyndman, M. Eric, Braden Manns, Peter J. Bridge, et al.. (2000). Oral vitamin B12 lowers homocysteine in patients with ESRD more effectively in the homozygous T/T MTHFR 677 patients. Atherosclerosis. 151(1). 58–58.
12.
Bridge, Peter J., et al.. (1997). Maternal uniparental heterodisomy for chromosome 16: Case report. American Journal of Medical Genetics. 70(4). 387–390. 15 indexed citations
13.
Bremner, Rod, et al.. (1997). Deletion of RBExons 24 and 25 Causes Low-Penetrance Retinoblastoma. The American Journal of Human Genetics. 61(3). 556–570. 64 indexed citations
14.
Christodoulou, John, Roderick R. McInnes, Venita Jay, et al.. (1994). Barth syndrome: Clinical observations and genetic linkage studies. American Journal of Medical Genetics. 50(3). 255–264. 87 indexed citations
15.
Bridge, Peter J., et al.. (1992). An A to T transversion at position −5 of the Factor IX promoter results in hemophilia B. Genomics. 12(1). 161–163. 15 indexed citations
16.
Bridge, Peter J., Patrick MacLeod, & David Lillicrap. (1991). Carrier detection and prenatal diagnosis of Pelizaeus‐Merzbacher disease using a combination of anonymous DNA polymorphisms and the proteolipid protein (PLP) gene cDNA. American Journal of Medical Genetics. 38(4). 616–621. 5 indexed citations
17.
Taylor, Sherryl A., Peter J. Bridge, & D Lillicrap. (1989). A BstXI polymorphism detected by the factor VIII genomic probe p.482.6 (F8C). Nucleic Acids Research. 17(15). 6426–6426. 2 indexed citations
18.
Bridge, Peter J. & David Lillicrap. (1989). Molecular diagnosis of the fragile X [Fra (X)] syndrome: Calculation of risks based on flanking DNA markers in small phase‐unknown families. American Journal of Medical Genetics. 33(1). 92–99. 6 indexed citations
19.
Bridge, Peter J., et al.. (1985). Postmortem Central Catecholamines and Antemortem Cognitive Impairment in Elderly Schizophrenics and Controls. Neuropsychobiology. 14(2). 57–61. 20 indexed citations
20.
Nickel, Ernest H., et al.. (1977). Eardleyite as a product of the supergene alteration of nickel sulfides in Western Australia. American Mineralogist. 62. 449–457. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuichi Mori Breakdown of academic impact, for papers by Kei Matsumoto Breakdown of academic impact, for papers by Jean‐Paul Moisan Breakdown of academic impact, for papers by Brian K. Roberts Breakdown of academic impact, for papers by Yoshiaki Yamada Breakdown of academic impact, for papers by Emma Moore Breakdown of academic impact, for papers by Gerard N. Burrow Breakdown of academic impact, for papers by Helen Turner Breakdown of academic impact, for papers by Kristy Lee Breakdown of academic impact, for papers by F. A. Beemer
Rankless by CCL
2026